Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 111,600 shares, a decrease of 60.6% from the December 31st total of 283,600 shares. Currently, 9.0% of the company’s stock are sold short. Based on an average daily trading volume, of 831,600 shares, the short-interest ratio is presently 0.1 days.

Autonomix Medical Stock Performance

Shares of Autonomix Medical stock traded down $0.08 during midday trading on Thursday, hitting $3.02. The company had a trading volume of 53,870 shares, compared to its average volume of 368,096. The company has a fifty day simple moving average of $3.79 and a 200 day simple moving average of $10.69. The stock has a market cap of $3.47 million and a price-to-earnings ratio of -0.19. The company has a quick ratio of 4.26, a current ratio of 4.26 and a debt-to-equity ratio of 0.36. Autonomix Medical has a 12-month low of $2.55 and a 12-month high of $121.80.

Autonomix Medical (NASDAQ:AMIX) last posted its quarterly earnings data on Friday, November 8th. The company reported ($2.47) EPS for the quarter. As a group, analysts predict that Autonomix Medical will post -10 earnings per share for the current fiscal year.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.